首页> 外国专利> monoclonal antibody or binding fragment, isolated nucleic acid molecule, vector, host cell, methods for preparing the monoclonal antibody or binding fragment in vivo or in vitro and for prevention and / or treatment and / or adjuvant therapy and / or diagnosis of a tumor, conjugate, kit, use of a monoclonal antibody or binding fragment, and pharmaceutical composition?

monoclonal antibody or binding fragment, isolated nucleic acid molecule, vector, host cell, methods for preparing the monoclonal antibody or binding fragment in vivo or in vitro and for prevention and / or treatment and / or adjuvant therapy and / or diagnosis of a tumor, conjugate, kit, use of a monoclonal antibody or binding fragment, and pharmaceutical composition?

机译:单克隆抗体或结合片段,分离的核酸分子,载体,宿主细胞,体内或体外制备单克隆抗体或结合片段以及预防和/或治疗和/或辅助治疗和/或诊断肿瘤的方法,偶联物,试剂盒,单克隆抗体或结合片段的用途以及药物组合物?

摘要

The present invention belongs to the fields of tumor treatment and molecular immunology and provides an anti-ctla4 monoclonal antibody or antigen binding fragment thereof, a medicinal composition thereof and a use thereof. The monoclonal antibody of the present invention prevents clta4 from binding to b7, thereby eliminating the immunosuppressive effect of ctla4 in the host and activating t lymphocytes.
机译:本发明属于肿瘤治疗和分子免疫学领域,并提供抗ctla4单克隆抗体或其抗原结合片段,其药物组合物及其用途。本发明的单克隆抗体防止clta4与b7结合,从而消除了ctla4在宿主中的免疫抑制作用并激活了t淋巴细胞。

著录项

  • 公开/公告号BR112017002080A2

    专利类型

  • 公开/公告日2018-02-27

    原文格式PDF

  • 申请/专利权人 AKESO BIOPHARMA INC.;

    申请/专利号BR20171102080

  • 申请日2015-07-31

  • 分类号A61K39/395;A61P35;A61P37/04;C07K16/28;C07K19;C12N1/21;C12N5/10;C12N15/13;C12N15/63;G01N33/577;

  • 国家 BR

  • 入库时间 2022-08-21 12:53:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号